← FDA DRUG APPROVALS

FDA ANDA · ANDA062058

AMOXICILLIN

Sponsor: CHARTWELL

APPLICATION
ANDA062058
TYPE
ANDA
ORIGINAL APPROVAL
1978-08-03
LATEST ACTION
2024-05-01
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

AMOXICILLINPrescription
AMOXICILLIN 250MG · CAPSULE · ORAL
AMOXICILLINPrescription
AMOXICILLIN 500MG · CAPSULE · ORAL

Approval history

2024-05-01Labeling · Supplement 15 · standardAP
2011-02-07Labeling · Supplement 8AP
1997-07-15Labeling · Supplement 1AP
1978-08-03OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →